Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
COVID-19 pandemic
|
194,247
|
6,266
|
GA
|
Top
|
2
|
Marburg virus
|
183,313
|
5,913
|
C
|
High
|
3
|
COVID-19
|
181,527
|
5,855
|
C
|
Top
|
4
|
Norovirus
|
162,148
|
5,230
|
B
|
Top
|
5
|
Hand, foot, and mouth disease
|
120,021
|
3,871
|
B
|
High
|
6
|
HIV/AIDS
|
114,604
|
3,696
|
GA
|
Top
|
7
|
Epstein–Barr virus
|
110,493
|
3,564
|
B
|
Top
|
8
|
Rabies
|
108,087
|
3,486
|
B
|
Top
|
9
|
Respiratory syncytial virus
|
103,749
|
3,346
|
B
|
High
|
10
|
Herpes simplex virus
|
98,293
|
3,170
|
B
|
Top
|
11
|
List of epidemics and pandemics
|
93,260
|
3,008
|
List
|
High
|
12
|
Smallpox
|
91,574
|
2,954
|
GA
|
Top
|
13
|
Shingles
|
89,498
|
2,887
|
GA
|
Top
|
14
|
Human papillomavirus infection
|
84,348
|
2,720
|
B
|
Top
|
15
|
Rhinovirus
|
83,628
|
2,697
|
C
|
High
|
16
|
Dengue fever
|
79,797
|
2,574
|
FA
|
Top
|
17
|
Spanish flu
|
78,964
|
2,547
|
GA
|
Top
|
18
|
Creutzfeldt–Jakob disease
|
72,212
|
2,329
|
B
|
Top
|
19
|
Virus
|
71,300
|
2,300
|
FA
|
Top
|
20
|
Prion
|
69,829
|
2,252
|
GA
|
Top
|
21
|
HIV
|
67,897
|
2,190
|
GA
|
Top
|
22
|
Infectious mononucleosis
|
66,649
|
2,149
|
B
|
Top
|
23
|
Polio
|
66,293
|
2,138
|
B
|
Top
|
24
|
Measles
|
63,448
|
2,046
|
B
|
Top
|
25
|
Hodgkin lymphoma
|
61,028
|
1,968
|
B
|
Top
|
26
|
Chickenpox
|
57,440
|
1,852
|
B
|
Top
|
27
|
Gastroenteritis
|
54,799
|
1,767
|
GA
|
Top
|
28
|
Canine parvovirus
|
54,713
|
1,764
|
B
|
Top
|
29
|
Molluscum contagiosum
|
53,412
|
1,722
|
B
|
High
|
30
|
Bell's palsy
|
52,154
|
1,682
|
B
|
Top
|
31
|
Herpes
|
51,905
|
1,674
|
GA
|
Top
|
32
|
COVID-19 vaccine
|
50,568
|
1,631
|
C
|
Top
|
33
|
Marburg virus disease
|
48,391
|
1,561
|
C
|
High
|
34
|
Rotavirus
|
47,593
|
1,535
|
FA
|
Top
|
35
|
HPV vaccine
|
46,035
|
1,485
|
B
|
High
|
36
|
Influenza
|
42,514
|
1,371
|
FA
|
High
|
37
|
Chronic wasting disease
|
42,001
|
1,354
|
C
|
Top
|
38
|
Ebola
|
41,930
|
1,352
|
B
|
Top
|
39
|
Rosalind Franklin
|
41,514
|
1,339
|
B
|
High
|
40
|
COVID-19 pandemic in the United States
|
40,615
|
1,310
|
B
|
Low
|
41
|
Respiratory syncytial virus vaccine
|
40,014
|
1,290
|
B
|
Mid
|
42
|
Mpox
|
38,859
|
1,253
|
C
|
High
|
43
|
Cytomegalovirus
|
38,722
|
1,249
|
B
|
Top
|
44
|
SARS-CoV-2
|
37,010
|
1,193
|
B
|
Top
|
45
|
Hepatitis C
|
36,920
|
1,190
|
GA
|
Top
|
46
|
Common cold
|
36,861
|
1,189
|
GA
|
Top
|
47
|
Croup
|
36,570
|
1,179
|
GA
|
Top
|
48
|
Mumps
|
33,361
|
1,076
|
B
|
Top
|
49
|
Variant Creutzfeldt–Jakob disease
|
33,127
|
1,068
|
B
|
High
|
50
|
Yellow fever
|
31,481
|
1,015
|
B
|
Top
|
51
|
Coronavirus
|
31,316
|
1,010
|
C
|
High
|
52
|
Influenza A virus
|
31,149
|
1,004
|
B
|
Top
|
53
|
Hepatitis B
|
30,902
|
996
|
GA
|
Top
|
54
|
Timeline of the COVID-19 pandemic
|
30,727
|
991
|
List
|
Top
|
55
|
Foot-and-mouth disease
|
29,864
|
963
|
B
|
High
|
56
|
Bacteriophage
|
29,466
|
950
|
B
|
Top
|
57
|
Canine distemper
|
29,156
|
940
|
B
|
Top
|
58
|
Vaccine
|
28,302
|
912
|
B
|
Top
|
59
|
West Nile virus
|
28,093
|
906
|
B
|
High
|
60
|
Chikungunya
|
28,086
|
906
|
B
|
High
|
61
|
COVID-19 pandemic by country and territory
|
27,182
|
876
|
List
|
Top
|
62
|
COVID-19 lockdown in India
|
26,924
|
868
|
B
|
Mid
|
63
|
HeLa
|
25,959
|
837
|
C
|
Mid
|
64
|
Genital herpes
|
25,691
|
828
|
C
|
High
|
65
|
Cold sore
|
25,483
|
822
|
C
|
Top
|
66
|
Varicella zoster virus
|
25,087
|
809
|
C
|
High
|
67
|
History of HIV/AIDS
|
24,840
|
801
|
B
|
Top
|
68
|
Rubella
|
24,650
|
795
|
B
|
Top
|
69
|
Genital wart
|
24,463
|
789
|
B
|
Top
|
70
|
Remdesivir
|
24,131
|
778
|
C
|
High
|
71
|
Influenza vaccine
|
21,972
|
708
|
B
|
Top
|
72
|
Cervical cancer
|
21,818
|
703
|
B
|
High
|
73
|
Pandemic
|
21,733
|
701
|
B
|
High
|
74
|
Messenger RNA
|
21,546
|
695
|
C
|
High
|
75
|
Adenoviridae
|
21,532
|
694
|
B
|
High
|
76
|
Feline leukemia virus
|
21,481
|
692
|
C
|
High
|
77
|
Kaposi's sarcoma
|
20,527
|
662
|
C
|
Mid
|
78
|
List of COVID-19 vaccine authorizations
|
20,431
|
659
|
List
|
Mid
|
79
|
Hepatitis A
|
19,985
|
644
|
B
|
Top
|
80
|
Edward Jenner
|
19,838
|
639
|
B
|
High
|
81
|
Enterovirus
|
19,403
|
625
|
C
|
High
|
82
|
COVID-19 lockdowns
|
19,219
|
619
|
B
|
Low
|
83
|
COVID-19 lab leak theory
|
19,077
|
615
|
B
|
Low
|
84
|
Smallpox vaccine
|
17,879
|
576
|
B
|
Mid
|
85
|
Amantadine
|
17,730
|
571
|
C
|
High
|
86
|
Coxsackievirus
|
17,428
|
562
|
C
|
High
|
87
|
Lassa fever
|
17,405
|
561
|
C
|
High
|
88
|
Feline infectious peritonitis
|
17,100
|
551
|
C
|
High
|
89
|
Influenza B virus
|
16,903
|
545
|
C
|
High
|
90
|
Epidemiology of HIV/AIDS
|
16,750
|
540
|
C
|
High
|
91
|
SARS
|
16,389
|
528
|
C
|
Top
|
92
|
Human metapneumovirus
|
16,136
|
520
|
C
|
High
|
93
|
Orthohantavirus
|
15,889
|
512
|
B
|
Top
|
94
|
COVID-19 pandemic in India
|
15,701
|
506
|
B
|
High
|
95
|
Viral hemorrhagic fever
|
15,692
|
506
|
C
|
High
|
96
|
Operation Warp Speed
|
15,395
|
496
|
C
|
High
|
97
|
Zika virus
|
15,190
|
490
|
B
|
Top
|
98
|
Disease X
|
15,164
|
489
|
GA
|
Low
|
99
|
2009 swine flu pandemic
|
15,093
|
486
|
GA
|
High
|
100
|
Rabies virus
|
14,924
|
481
|
C
|
Top
|
101
|
COVID-19 pandemic deaths
|
14,684
|
473
|
C
|
Low
|
102
|
SV40
|
14,411
|
464
|
C
|
Mid
|
103
|
Antiviral drug
|
14,351
|
462
|
C
|
Top
|
104
|
List of deaths due to COVID-19
|
14,287
|
460
|
List
|
High
|
105
|
Monkeypox virus
|
14,284
|
460
|
C
|
Mid
|
106
|
Eastern equine encephalitis
|
14,206
|
458
|
C
|
Mid
|
107
|
Retrovirus
|
13,566
|
437
|
C
|
Top
|
108
|
Nipah virus
|
13,329
|
429
|
Start
|
Mid
|
109
|
Varicella vaccine
|
13,237
|
427
|
B
|
Top
|
110
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
13,074
|
421
|
C
|
Low
|
111
|
Vaccination
|
12,917
|
416
|
B
|
Top
|
112
|
Parvovirus B19
|
12,866
|
415
|
C
|
Mid
|
113
|
Human parainfluenza viruses
|
12,864
|
414
|
C
|
Mid
|
114
|
Roseola
|
12,692
|
409
|
C
|
High
|
115
|
COVID-19 misinformation
|
12,426
|
400
|
C
|
Low
|
116
|
COVID-19 pandemic in Russia
|
12,329
|
397
|
C
|
Low
|
117
|
Influenza A virus subtype H1N1
|
12,234
|
394
|
C
|
Top
|
118
|
Interferon
|
12,197
|
393
|
B
|
Top
|
119
|
HIV/AIDS in the United States
|
11,934
|
384
|
C
|
Low
|
120
|
Feline immunodeficiency virus
|
11,818
|
381
|
C
|
High
|
121
|
Zidovudine
|
11,575
|
373
|
B
|
High
|
122
|
SARS-CoV-2 Omicron variant
|
11,553
|
372
|
C
|
High
|
123
|
Herpesviridae
|
11,299
|
364
|
C
|
Top
|
124
|
Moderna
|
11,146
|
359
|
C
|
Low
|
125
|
Index case
|
11,041
|
356
|
Start
|
Low
|
126
|
Measles vaccine
|
11,001
|
354
|
C
|
Low
|
127
|
Viral pneumonia
|
10,948
|
353
|
Start
|
High
|
128
|
2002–2004 SARS outbreak
|
10,821
|
349
|
B
|
Mid
|
129
|
Symptoms of COVID-19
|
10,785
|
347
|
C
|
Low
|
130
|
Origin of SARS-CoV-2
|
10,702
|
345
|
C
|
Mid
|
131
|
Tobacco mosaic virus
|
10,646
|
343
|
C
|
High
|
132
|
Compartmental models in epidemiology
|
10,514
|
339
|
C
|
Mid
|
133
|
Rinderpest
|
10,447
|
337
|
B
|
High
|
134
|
Avian influenza
|
10,266
|
331
|
B
|
High
|
135
|
Western African Ebola epidemic
|
10,050
|
324
|
GA
|
Mid
|
136
|
Dengue virus
|
9,771
|
315
|
B
|
Top
|
137
|
Myxomatosis
|
9,755
|
314
|
GA
|
High
|
138
|
RNA interference
|
9,711
|
313
|
FA
|
High
|
139
|
Oropouche fever
|
9,665
|
311
|
C
|
Low
|
140
|
Diagnosis of HIV/AIDS
|
9,608
|
309
|
B
|
High
|
141
|
SARS-CoV-1
|
9,400
|
303
|
C
|
High
|
142
|
Alphapithovirus
|
9,380
|
302
|
C
|
High
|
143
|
Xenophobia and racism related to the COVID-19 pandemic
|
9,365
|
302
|
List
|
Low
|
144
|
Viral hepatitis
|
9,250
|
298
|
C
|
High
|
145
|
Bluetongue disease
|
9,121
|
294
|
B
|
High
|
146
|
Gardasil
|
9,103
|
293
|
B
|
High
|
147
|
Poliovirus
|
8,928
|
288
|
GA
|
High
|
148
|
2023–2024 mpox epidemic
|
8,924
|
287
|
C
|
Mid
|
149
|
Zaire ebolavirus
|
8,789
|
283
|
C
|
Top
|
150
|
Merkel-cell carcinoma
|
8,731
|
281
|
C
|
Mid
|
151
|
Variants of SARS-CoV-2
|
8,623
|
278
|
C
|
Mid
|
152
|
COVID-19 pandemic in the United Kingdom
|
8,543
|
275
|
C
|
Low
|
153
|
West Nile fever
|
8,479
|
273
|
C
|
High
|
154
|
Virus classification
|
8,382
|
270
|
C
|
Top
|
155
|
Japanese encephalitis
|
8,350
|
269
|
B
|
High
|
156
|
Dengue vaccine
|
8,317
|
268
|
C
|
Low
|
157
|
Viral disease
|
8,147
|
262
|
List
|
Top
|
158
|
Human herpesvirus 6
|
8,136
|
262
|
C
|
High
|
159
|
Hantavirus pulmonary syndrome
|
8,127
|
262
|
Start
|
High
|
160
|
Wuhan Institute of Virology
|
8,114
|
261
|
C
|
Mid
|
161
|
Timeline of HIV/AIDS
|
8,069
|
260
|
List
|
Mid
|
162
|
DNA polymerase
|
7,731
|
249
|
C
|
Top
|
163
|
Yellow fever vaccine
|
7,724
|
249
|
C
|
High
|
164
|
Rotavirus vaccine
|
7,561
|
243
|
C
|
High
|
165
|
Rabies in animals
|
7,415
|
239
|
C
|
High
|
166
|
RNA polymerase
|
7,354
|
237
|
B
|
High
|
167
|
COVID-19 pandemic in the Philippines
|
7,204
|
232
|
B
|
Low
|
168
|
Influenza A virus subtype H5N1
|
7,188
|
231
|
B
|
Top
|
169
|
Subacute sclerosing panencephalitis
|
7,117
|
229
|
C
|
Mid
|
170
|
Bioterrorism
|
7,082
|
228
|
B
|
Low
|
171
|
Feline calicivirus
|
7,069
|
228
|
C
|
Top
|
172
|
1889–1890 pandemic
|
6,845
|
220
|
C
|
Mid
|
173
|
Reverse transcriptase
|
6,844
|
220
|
B
|
Top
|
174
|
Economic impact of the COVID-19 pandemic
|
6,838
|
220
|
B
|
Low
|
175
|
Filoviridae
|
6,806
|
219
|
Start
|
High
|
176
|
Vaccine hesitancy
|
6,663
|
214
|
B
|
High
|
177
|
Swine influenza
|
6,645
|
214
|
B
|
High
|
178
|
Lady Mary Wortley Montagu
|
6,592
|
212
|
B
|
Low
|
179
|
Cowpox
|
6,493
|
209
|
C
|
Mid
|
180
|
Human alphaherpesvirus 2
|
6,390
|
206
|
Start
|
Mid
|
181
|
RNA virus
|
6,383
|
205
|
B
|
High
|
182
|
Hong Kong flu
|
6,376
|
205
|
C
|
Low
|
183
|
Viral encephalitis
|
6,374
|
205
|
B
|
High
|
184
|
Host (biology)
|
6,363
|
205
|
GA
|
High
|
185
|
Hepatitis C virus
|
6,351
|
204
|
B
|
Top
|
186
|
History of smallpox
|
6,347
|
204
|
C
|
Mid
|
187
|
Herpes simplex encephalitis
|
6,342
|
204
|
Start
|
Low
|
188
|
COVID-19 pandemic in Australia
|
6,342
|
204
|
B
|
Low
|
189
|
Human T-lymphotropic virus 1
|
6,312
|
203
|
C
|
High
|
190
|
Orthomyxoviridae
|
6,274
|
202
|
B
|
High
|
191
|
Polio eradication
|
6,252
|
201
|
B
|
Mid
|
192
|
COVID-19 vaccine misinformation and hesitancy
|
6,137
|
197
|
B
|
Top
|
193
|
Hershey–Chase experiment
|
6,120
|
197
|
C
|
Mid
|
194
|
Viroid
|
6,050
|
195
|
C
|
High
|
195
|
Human polyomavirus 2
|
6,040
|
194
|
C
|
High
|
196
|
Pithovirus
|
6,030
|
194
|
Redirect
|
NA
|
197
|
COVID-19 vaccination mandates in the United States
|
6,025
|
194
|
Start
|
Low
|
198
|
Crimean–Congo hemorrhagic fever
|
6,022
|
194
|
C
|
High
|
199
|
Impact of the COVID-19 pandemic on cinema
|
5,978
|
192
|
B
|
Low
|
200
|
Lyssavirus
|
5,968
|
192
|
C
|
Mid
|
201
|
Subtypes of HIV
|
5,950
|
191
|
C
|
High
|
202
|
Virology
|
5,877
|
189
|
B
|
Top
|
203
|
Lysogenic cycle
|
5,791
|
186
|
C
|
High
|
204
|
Henipavirus
|
5,788
|
186
|
C
|
High
|
205
|
MOG antibody disease
|
5,721
|
184
|
C
|
Mid
|
206
|
COVID-19 pandemic in mainland China
|
5,629
|
181
|
C
|
High
|
207
|
Hepatitis B virus
|
5,615
|
181
|
C
|
Top
|
208
|
2022–2023 mpox outbreak
|
5,517
|
177
|
B
|
Mid
|
209
|
Lentivirus
|
5,480
|
176
|
C
|
Mid
|
210
|
Great Barrington Declaration
|
5,463
|
176
|
B
|
Low
|
211
|
Attenuated vaccine
|
5,459
|
176
|
C
|
High
|
212
|
Tick-borne encephalitis
|
5,417
|
174
|
Start
|
Low
|
213
|
Ebolavirus
|
5,410
|
174
|
C
|
Mid
|
214
|
MERS
|
5,371
|
173
|
B
|
High
|
215
|
1978 smallpox outbreak in the United Kingdom
|
5,367
|
173
|
B
|
Low
|
216
|
Marburgvirus
|
5,322
|
171
|
C
|
High
|
217
|
COVID-19 pandemic in Canada
|
5,321
|
171
|
B
|
Mid
|
218
|
Capsid
|
5,261
|
169
|
C
|
Top
|
219
|
Adeno-associated virus
|
5,254
|
169
|
B
|
High
|
220
|
Severe acute respiratory syndrome coronavirus 2
|
5,231
|
168
|
Redirect
|
NA
|
221
|
Walter Reed
|
5,221
|
168
|
C
|
Low
|
222
|
Hepatitis E
|
5,206
|
167
|
GA
|
High
|
223
|
Phage therapy
|
5,172
|
166
|
C
|
Top
|
224
|
COVID-19 pandemic in New Zealand
|
5,166
|
166
|
C
|
Low
|
225
|
1967 Marburg virus disease outbreak
|
5,150
|
166
|
C
|
Low
|
226
|
Variolation
|
5,120
|
165
|
C
|
High
|
227
|
History of virology
|
5,042
|
162
|
B
|
Top
|
228
|
COVID-19 testing
|
5,005
|
161
|
B
|
Low
|
229
|
Poxviridae
|
4,974
|
160
|
C
|
High
|
230
|
Viral envelope
|
4,967
|
160
|
Start
|
Top
|
231
|
Transduction (genetics)
|
4,891
|
157
|
C
|
High
|
232
|
Vaccine shedding
|
4,874
|
157
|
Start
|
Mid
|
233
|
Lambda phage
|
4,872
|
157
|
B
|
High
|
234
|
COVID-19 pandemic in Victoria
|
4,861
|
156
|
C
|
Low
|
235
|
Human alphaherpesvirus 1
|
4,829
|
155
|
Start
|
Mid
|
236
|
Hammer-headed bat
|
4,818
|
155
|
GA
|
Low
|
237
|
Timeline of the COVID-19 pandemic in 2019
|
4,801
|
154
|
List
|
High
|
238
|
Flavivirus
|
4,786
|
154
|
B
|
High
|
239
|
2001 United Kingdom foot-and-mouth outbreak
|
4,771
|
153
|
C
|
Mid
|
240
|
Feline coronavirus
|
4,770
|
153
|
C
|
Mid
|
241
|
Ebola virus cases in the United States
|
4,769
|
153
|
C
|
High
|
242
|
DNA virus
|
4,752
|
153
|
C
|
Top
|
243
|
Sapovirus
|
4,713
|
152
|
C
|
High
|
244
|
Gain-of-function research
|
4,712
|
152
|
Start
|
High
|
245
|
BK virus
|
4,705
|
151
|
B
|
Low
|
246
|
Shope papilloma virus
|
4,693
|
151
|
C
|
Mid
|
247
|
Rhabdoviridae
|
4,653
|
150
|
C
|
High
|
248
|
Lytic cycle
|
4,642
|
149
|
C
|
High
|
249
|
Orthopoxvirus
|
4,639
|
149
|
C
|
High
|
250
|
Parvoviridae
|
4,622
|
149
|
B
|
Mid
|
251
|
Malaysian movement control order
|
4,575
|
147
|
B
|
Low
|
252
|
Hepatitis D
|
4,535
|
146
|
C
|
Mid
|
253
|
Virulence
|
4,524
|
145
|
C
|
High
|
254
|
List of films impacted by the COVID-19 pandemic
|
4,485
|
144
|
List
|
Mid
|
255
|
Richard H. Ebright
|
4,480
|
144
|
Start
|
Mid
|
256
|
List of Ebola outbreaks
|
4,472
|
144
|
List
|
Low
|
257
|
Carcinogenesis
|
4,471
|
144
|
B
|
Mid
|
258
|
Papillomaviridae
|
4,468
|
144
|
B
|
Top
|
259
|
Non-cellular life
|
4,414
|
142
|
Start
|
Low
|
260
|
Incertae sedis
|
4,381
|
141
|
C
|
Low
|
261
|
Adenovirus infection
|
4,363
|
140
|
Start
|
Mid
|
262
|
Baltimore classification
|
4,333
|
139
|
B
|
Top
|
263
|
Molnupiravir
|
4,305
|
138
|
C
|
Mid
|
264
|
Kaposi's sarcoma-associated herpesvirus
|
4,301
|
138
|
C
|
High
|
265
|
MERS-related coronavirus
|
4,269
|
137
|
B
|
High
|
266
|
Picornavirus
|
4,236
|
136
|
B
|
Mid
|
267
|
Positive-strand RNA virus
|
4,214
|
135
|
C
|
High
|
268
|
Rabbit hemorrhagic disease
|
4,195
|
135
|
B
|
Mid
|
269
|
Pod People (Invasion of the Body Snatchers)
|
4,180
|
134
|
Start
|
Low
|
270
|
GS-441524
|
4,180
|
134
|
Start
|
Low
|
271
|
Eczema herpeticum
|
4,132
|
133
|
Start
|
Low
|
272
|
Pandemic H1N1/09 virus
|
4,105
|
132
|
C
|
Mid
|
273
|
Oncovirus
|
4,100
|
132
|
C
|
Top
|
274
|
Reston virus
|
4,048
|
130
|
C
|
Low
|
275
|
Face masks during the COVID-19 pandemic
|
4,038
|
130
|
C
|
Low
|
276
|
Impact of the COVID-19 pandemic on education
|
4,021
|
129
|
C
|
Low
|
277
|
Escherichia virus T4
|
4,019
|
129
|
Start
|
Mid
|
278
|
Sense (molecular biology)
|
3,998
|
128
|
C
|
High
|
279
|
Flat wart
|
3,996
|
128
|
Stub
|
Mid
|
280
|
COVID-19 pandemic in Italy
|
3,980
|
128
|
C
|
Mid
|
281
|
COVID-19 vaccination in the United States
|
3,933
|
126
|
Start
|
Low
|
282
|
Vaccinia
|
3,926
|
126
|
C
|
High
|
283
|
History of coronavirus
|
3,921
|
126
|
B
|
Mid
|
284
|
COVID-19 pandemic in Hubei
|
3,919
|
126
|
C
|
Mid
|
285
|
Metagenomics
|
3,895
|
125
|
GA
|
High
|
286
|
Strain (biology)
|
3,848
|
124
|
C
|
High
|
287
|
COVID-19 lockdown in China
|
3,813
|
123
|
C
|
High
|
288
|
Nipah virus infection
|
3,811
|
122
|
C
|
High
|
289
|
COVID-19 pandemic in the Republic of Ireland
|
3,803
|
122
|
C
|
Low
|
290
|
Measles virus
|
3,797
|
122
|
C
|
Top
|
291
|
Inclusion bodies
|
3,797
|
122
|
C
|
High
|
292
|
HBsAg
|
3,795
|
122
|
Start
|
High
|
293
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
3,784
|
122
|
C
|
Mid
|
294
|
Influenza pandemic
|
3,782
|
122
|
B
|
Top
|
295
|
History of COVID-19 vaccine development
|
3,767
|
121
|
C
|
Low
|
296
|
Coronavirus spike protein
|
3,753
|
121
|
Start
|
Low
|
297
|
Viral replication
|
3,752
|
121
|
C
|
Top
|
298
|
Negative-strand RNA virus
|
3,690
|
119
|
B
|
Mid
|
299
|
Echovirus
|
3,673
|
118
|
List
|
Mid
|
300
|
Rubella virus
|
3,618
|
116
|
C
|
High
|
301
|
COVID-19 pandemic in North Korea
|
3,617
|
116
|
B
|
Mid
|
302
|
1977 Russian flu
|
3,594
|
115
|
C
|
Mid
|
303
|
African swine fever virus
|
3,587
|
115
|
C
|
High
|
304
|
SARS-CoV-2 Delta variant
|
3,586
|
115
|
C
|
Mid
|
305
|
Ravn virus
|
3,576
|
115
|
Start
|
Low
|
306
|
2019 Samoa measles outbreak
|
3,567
|
115
|
C
|
Low
|
307
|
Viral shedding
|
3,546
|
114
|
Start
|
High
|
308
|
Virulent Newcastle disease
|
3,534
|
114
|
C
|
High
|
309
|
Ivermectin during the COVID-19 pandemic
|
3,494
|
112
|
B
|
Low
|
310
|
Arbovirus
|
3,490
|
112
|
C
|
Top
|
311
|
COVID-19 pandemic in New York City
|
3,456
|
111
|
Start
|
Low
|
312
|
Ebola vaccine
|
3,455
|
111
|
C
|
Mid
|
313
|
Australian bat lyssavirus
|
3,436
|
110
|
C
|
Low
|
314
|
Giant virus
|
3,422
|
110
|
C
|
High
|
315
|
COVID-19 pandemic in Singapore
|
3,421
|
110
|
B
|
High
|
316
|
Zika fever
|
3,418
|
110
|
B
|
High
|
317
|
Travel during the COVID-19 pandemic
|
3,413
|
110
|
C
|
Low
|
318
|
Carnivore protoparvovirus 1
|
3,395
|
109
|
Start
|
Mid
|
319
|
Influenza A virus subtype H3N2
|
3,393
|
109
|
C
|
High
|
320
|
Feed a cold, starve a fever
|
3,378
|
108
|
C
|
Low
|
321
|
List of biosafety level 4 organisms
|
3,369
|
108
|
List
|
Low
|
322
|
COVID-19 pandemic in Japan
|
3,356
|
108
|
C
|
Low
|
323
|
Simian immunodeficiency virus
|
3,345
|
107
|
C
|
High
|
324
|
Human betaherpesvirus 5
|
3,339
|
107
|
C
|
High
|
325
|
Koplik's spots
|
3,287
|
106
|
C
|
Mid
|
326
|
1957–1958 influenza pandemic
|
3,276
|
105
|
C
|
Mid
|
327
|
White House Coronavirus Task Force
|
3,235
|
104
|
C
|
Low
|
328
|
Rift Valley fever
|
3,223
|
103
|
C
|
High
|
329
|
COVID-19 vaccination in India
|
3,197
|
103
|
C
|
Low
|
330
|
Spike protein
|
3,184
|
102
|
Start
|
Low
|
331
|
Intracellular parasite
|
3,181
|
102
|
Start
|
Mid
|
332
|
Paramyxoviridae
|
3,160
|
101
|
C
|
High
|
333
|
Ebola virus
|
3,148
|
101
|
Redirect
|
NA
|
334
|
Phage display
|
3,146
|
101
|
C
|
Mid
|
335
|
HIV trial in Libya
|
3,082
|
99
|
B
|
Low
|
336
|
HIV vaccine development
|
3,067
|
98
|
C
|
Mid
|
337
|
Timeline of the COVID-19 pandemic in Canada
|
3,040
|
98
|
B
|
Mid
|
338
|
B virus
|
3,015
|
97
|
C
|
Mid
|
339
|
Natural reservoir
|
3,005
|
96
|
C
|
High
|
340
|
COVID-19 pandemic in Germany
|
3,000
|
96
|
C
|
Low
|
341
|
Rolling circle replication
|
2,985
|
96
|
C
|
Mid
|
342
|
Impact of the COVID-19 pandemic on the video game industry
|
2,985
|
96
|
C
|
Low
|
343
|
Lassa mammarenavirus
|
2,968
|
95
|
Start
|
Mid
|
344
|
U.S. federal government response to the COVID-19 pandemic
|
2,963
|
95
|
C
|
Mid
|
345
|
Riboviria
|
2,942
|
94
|
B
|
Top
|
346
|
Orf (disease)
|
2,926
|
94
|
Start
|
Low
|
347
|
COVID-19 pandemic on cruise ships
|
2,919
|
94
|
B
|
High
|
348
|
Invertebrate iridescent virus 31
|
2,903
|
93
|
Start
|
Low
|
349
|
RNA-dependent RNA polymerase
|
2,889
|
93
|
C
|
Top
|
350
|
Superinfection
|
2,882
|
92
|
Stub
|
Mid
|
351
|
Lamivudine
|
2,876
|
92
|
C
|
Mid
|
352
|
Viral evolution
|
2,873
|
92
|
C
|
High
|
353
|
COVID-19 pandemic in Europe
|
2,868
|
92
|
C
|
Low
|
354
|
Endogenous retrovirus
|
2,839
|
91
|
C
|
Mid
|
355
|
Solid lipid nanoparticle
|
2,837
|
91
|
C
|
Low
|
356
|
Discrimination against people with HIV/AIDS
|
2,834
|
91
|
C
|
High
|
357
|
Oncolytic virus
|
2,829
|
91
|
B
|
Mid
|
358
|
Coxsackie B virus
|
2,824
|
91
|
C
|
Mid
|
359
|
Hendra virus
|
2,811
|
90
|
Start
|
Mid
|
360
|
COVID-19 pandemic in New South Wales
|
2,806
|
90
|
B
|
Low
|
361
|
Human coronavirus NL63
|
2,795
|
90
|
C
|
Low
|
362
|
Timeline of human vaccines
|
2,783
|
89
|
List
|
Low
|
363
|
SARS-related coronavirus
|
2,779
|
89
|
C
|
High
|
364
|
List of unproven methods against COVID-19
|
2,761
|
89
|
List
|
Mid
|
365
|
Marek's disease
|
2,720
|
87
|
C
|
Mid
|
366
|
Mimivirus
|
2,719
|
87
|
C
|
Mid
|
367
|
Congenital rubella syndrome
|
2,649
|
85
|
Start
|
Mid
|
368
|
Smallpox virus retention debate
|
2,645
|
85
|
Start
|
Low
|
369
|
Flu season
|
2,638
|
85
|
C
|
High
|
370
|
1793 Philadelphia yellow fever epidemic
|
2,637
|
85
|
C
|
Low
|
371
|
Human coronavirus OC43
|
2,628
|
84
|
C
|
Mid
|
372
|
COVID-19 pandemic in South Africa
|
2,593
|
83
|
B
|
Mid
|
373
|
Vertically transmitted infection
|
2,580
|
83
|
C
|
High
|
374
|
Obelisk (biology)
|
2,578
|
83
|
Start
|
High
|
375
|
Astrovirus
|
2,554
|
82
|
B
|
Low
|
376
|
Antibody-dependent enhancement
|
2,533
|
81
|
C
|
High
|
377
|
Kyasanur Forest disease
|
2,525
|
81
|
B
|
Mid
|
378
|
Alphavirus
|
2,519
|
81
|
B
|
Mid
|
379
|
COVID-19 pandemic on Diamond Princess
|
2,514
|
81
|
Start
|
Low
|
380
|
Impact of the COVID-19 pandemic on the environment
|
2,494
|
80
|
C
|
Low
|
381
|
Mumps virus
|
2,488
|
80
|
B
|
High
|
382
|
Deployment of COVID-19 vaccines
|
2,467
|
79
|
C
|
High
|
383
|
Orthornavirae
|
2,465
|
79
|
B
|
High
|
384
|
Face masks during the COVID-19 pandemic in the United States
|
2,437
|
78
|
C
|
Low
|
385
|
1976 Zaire Ebola virus outbreak
|
2,398
|
77
|
C
|
Low
|
386
|
Innate resistance to HIV
|
2,386
|
76
|
C
|
High
|
387
|
Bat virome
|
2,383
|
76
|
GA
|
High
|
388
|
Polyomaviridae
|
2,369
|
76
|
C
|
High
|
389
|
COVID-19 pandemic in Malaysia
|
2,354
|
75
|
B
|
High
|
390
|
Flaviviridae
|
2,349
|
75
|
Start
|
High
|
391
|
Coxsackie A virus
|
2,342
|
75
|
Start
|
Mid
|
392
|
DNA vaccine
|
2,341
|
75
|
Start
|
Low
|
393
|
Viral vector vaccine
|
2,337
|
75
|
Start
|
Low
|
394
|
Impact of the COVID-19 pandemic on sports
|
2,336
|
75
|
C
|
Mid
|
395
|
COVID-19 pandemic in Maharashtra
|
2,334
|
75
|
C
|
Low
|
396
|
Hantavirus hemorrhagic fever with renal syndrome
|
2,330
|
75
|
Start
|
High
|
397
|
Virgin cleansing myth
|
2,316
|
74
|
Start
|
Low
|
398
|
Caliciviridae
|
2,313
|
74
|
C
|
Mid
|
399
|
Plant virus
|
2,312
|
74
|
C
|
Top
|
400
|
European respirator standards
|
2,293
|
73
|
C
|
Mid
|
401
|
Structure and genome of HIV
|
2,264
|
73
|
B
|
High
|
402
|
COVID-19 pandemic in Pakistan
|
2,260
|
72
|
B
|
Low
|
403
|
Molluscum contagiosum virus
|
2,258
|
72
|
C
|
Mid
|
404
|
COVID-19 pandemic in Tamil Nadu
|
2,251
|
72
|
C
|
Low
|
405
|
Primate T-lymphotropic virus
|
2,245
|
72
|
C
|
High
|
406
|
Heterophile antibody test
|
2,243
|
72
|
C
|
Low
|
407
|
Spillover infection
|
2,242
|
72
|
Start
|
Mid
|
408
|
COVID-19 pandemic in Sweden
|
2,236
|
72
|
B
|
Low
|
409
|
COVID-19 pandemic in California
|
2,232
|
72
|
C
|
Mid
|
410
|
Chandipura vesiculovirus
|
2,220
|
71
|
Start
|
Low
|
411
|
Transmission of COVID-19
|
2,215
|
71
|
C
|
High
|
412
|
Enterovirus 71
|
2,210
|
71
|
Start
|
High
|
413
|
Virus latency
|
2,208
|
71
|
C
|
High
|
414
|
Feline viral rhinotracheitis
|
2,193
|
70
|
C
|
Top
|
415
|
Bunyavirales
|
2,188
|
70
|
C
|
Mid
|
416
|
Oropouche orthobunyavirus
|
2,178
|
70
|
Start
|
Mid
|
417
|
Psittacine beak and feather disease
|
2,175
|
70
|
Start
|
Mid
|
418
|
Timeline of the COVID-19 pandemic in January 2020
|
2,168
|
69
|
List
|
High
|
419
|
Powassan virus
|
2,167
|
69
|
C
|
Mid
|
420
|
Chinese government response to COVID-19
|
2,156
|
69
|
B
|
Mid
|
421
|
Arenavirus
|
2,145
|
69
|
C
|
High
|
422
|
HIV/AIDS in Russia
|
2,129
|
68
|
Start
|
Low
|
423
|
Equine infectious anemia
|
2,111
|
68
|
Start
|
Mid
|
424
|
List of virus species
|
2,102
|
67
|
List
|
Top
|
425
|
COVID-19 pandemic in Hong Kong
|
2,096
|
67
|
C
|
Low
|
426
|
Impact of the COVID-19 pandemic on commercial air transport
|
2,091
|
67
|
C
|
Low
|
427
|
HA-tag
|
2,080
|
67
|
Start
|
High
|
428
|
Jonathan Van-Tam
|
2,068
|
66
|
C
|
Low
|
429
|
Emerging infectious disease
|
2,061
|
66
|
Start
|
Low
|
430
|
Pseudorabies
|
2,060
|
66
|
C
|
High
|
431
|
PEGylation
|
2,045
|
65
|
C
|
Low
|
432
|
Peter Daszak
|
2,016
|
65
|
Start
|
Low
|
433
|
SARS-CoV-2 Alpha variant
|
2,015
|
65
|
C
|
Low
|
434
|
List of diseases of the honey bee
|
2,006
|
64
|
List
|
High
|
435
|
Vaccine contamination with SV40
|
1,999
|
64
|
Start
|
Low
|
436
|
Introduction to viruses
|
1,990
|
64
|
FA
|
Top
|
437
|
Reverse-transcriptase inhibitor
|
1,985
|
64
|
C
|
High
|
438
|
Swedish government response to the COVID-19 pandemic
|
1,979
|
63
|
C
|
Low
|
439
|
Lymphocytic choriomeningitis
|
1,977
|
63
|
C
|
Mid
|
440
|
Human betaherpesvirus 7
|
1,971
|
63
|
C
|
Mid
|
441
|
COVID-19 vaccination in the United Kingdom
|
1,971
|
63
|
C
|
Low
|
442
|
Viral load
|
1,966
|
63
|
Start
|
Mid
|
443
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
1,958
|
63
|
List
|
Low
|
444
|
Pleomorphism (microbiology)
|
1,953
|
63
|
C
|
High
|
445
|
Fowlpox
|
1,950
|
62
|
Start
|
Low
|
446
|
COVID-19 pandemic in France
|
1,950
|
62
|
B
|
Mid
|
447
|
Cervarix
|
1,928
|
62
|
C
|
Mid
|
448
|
2020–21 Singapore circuit breaker measures
|
1,926
|
62
|
C
|
Low
|
449
|
COVID-19 pandemic in South Korea
|
1,914
|
61
|
B
|
Low
|
450
|
Conjugate vaccine
|
1,906
|
61
|
C
|
High
|
451
|
Timeline of the COVID-19 pandemic in March 2020
|
1,902
|
61
|
List
|
High
|
452
|
Cytopathic effect
|
1,900
|
61
|
C
|
High
|
453
|
Ross River virus
|
1,885
|
60
|
C
|
Mid
|
454
|
Koilocyte
|
1,879
|
60
|
Start
|
Low
|
455
|
HIV/AIDS in the Philippines
|
1,878
|
60
|
Start
|
Low
|
456
|
Sedoreoviridae
|
1,874
|
60
|
C
|
Mid
|
457
|
Baculoviridae
|
1,871
|
60
|
C
|
Mid
|
458
|
Natal multimammate mouse
|
1,860
|
60
|
Start
|
Low
|
459
|
Superspreading event
|
1,856
|
59
|
C
|
High
|
460
|
Double-stranded RNA viruses
|
1,852
|
59
|
Start
|
High
|
461
|
White House COVID-19 outbreak
|
1,841
|
59
|
C
|
Low
|
462
|
COVID-19 pandemic in New York (state)
|
1,826
|
58
|
C
|
Low
|
463
|
Black flying fox
|
1,818
|
58
|
C
|
Mid
|
464
|
U.S. state and local government responses to the COVID-19 pandemic
|
1,809
|
58
|
C
|
Mid
|
465
|
Shortages related to the COVID-19 pandemic
|
1,786
|
57
|
B
|
Low
|
466
|
Timeline of the COVID-19 pandemic in New York City
|
1,774
|
57
|
Start
|
Low
|
467
|
Banana bunchy top virus
|
1,766
|
56
|
C
|
Mid
|
468
|
Negri body
|
1,756
|
56
|
Start
|
Mid
|
469
|
COVID-19 misinformation by the United States
|
1,749
|
56
|
C
|
Low
|
470
|
COVID-19 pandemic in North America
|
1,740
|
56
|
C
|
Mid
|
471
|
Venezuelan equine encephalitis virus
|
1,735
|
55
|
Start
|
Mid
|
472
|
Prophage
|
1,715
|
55
|
C
|
Mid
|
473
|
Coronaviridae
|
1,705
|
55
|
Start
|
High
|
474
|
M13 bacteriophage
|
1,696
|
54
|
Start
|
Mid
|
475
|
Pandoravirus
|
1,693
|
54
|
Start
|
High
|
476
|
Enhanced community quarantine in Luzon
|
1,689
|
54
|
B
|
Low
|
477
|
Communication of the Trump administration during the COVID-19 pandemic
|
1,677
|
54
|
C
|
Low
|
478
|
Lentiviral vector in gene therapy
|
1,674
|
54
|
C
|
Low
|
479
|
Mpox in the Philippines
|
1,671
|
53
|
C
|
Low
|
480
|
Neurotropic virus
|
1,668
|
53
|
Start
|
High
|
481
|
Neonatal herpes
|
1,666
|
53
|
Start
|
High
|
482
|
Vertical transmission
|
1,658
|
53
|
C
|
Mid
|
483
|
Viremia
|
1,651
|
53
|
Start
|
High
|
484
|
Phi X 174
|
1,641
|
52
|
Start
|
Mid
|
485
|
Arcturus Therapeutics
|
1,617
|
52
|
C
|
Low
|
486
|
2020–2024 H5N1 outbreak
|
1,617
|
52
|
C
|
Low
|
487
|
Human bocavirus
|
1,609
|
51
|
C
|
Mid
|
488
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
1,608
|
51
|
List
|
Low
|
489
|
History of yellow fever
|
1,607
|
51
|
Start
|
Low
|
490
|
Enterovirus 68
|
1,599
|
51
|
C
|
Mid
|
491
|
Influenza C virus
|
1,575
|
50
|
Start
|
Low
|
492
|
COVID-19 pandemic in Kerala
|
1,574
|
50
|
C
|
Low
|
493
|
Bolivian hemorrhagic fever
|
1,565
|
50
|
Start
|
Mid
|
494
|
Lumpy skin disease
|
1,564
|
50
|
C
|
Mid
|
495
|
Realm (virology)
|
1,559
|
50
|
B
|
Top
|
496
|
HIV superinfection
|
1,557
|
50
|
C
|
Mid
|
497
|
735–737 Japanese smallpox epidemic
|
1,552
|
50
|
C
|
Low
|
498
|
Bacteriophage MS2
|
1,542
|
49
|
Start
|
Mid
|
499
|
COVID-19 pandemic in Florida
|
1,541
|
49
|
C
|
Low
|
500
|
Tecovirimat
|
1,536
|
49
|
C
|
Mid
|